The initiative reflects the PPD business’ vision to promote sustainability throughout the clinical development ecosystem.

Natera has announced positive results from the Phase III IMvigor011 clinical trial for muscle-invasive bladder cancer (MIBC).

These biotech IPOs plan to move forward during shutdown © 2025 American City Business Journals. All rights reserved. Use of ...

A new clinical trial led by University of Alberta researchers is exploring whether heavy strength training is a safe and ...

Moderna announced its decision to cease development of its vaccine mRNA-1647, which was being designed to treat birth defects ...

With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.

SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...

The termination of thousands of federal grants that fund clinical trials threatens to reverse substantial progress in ...

In contrast, a DL model can offer precise, AI-generated coding suggestions for adverse events and concomitant medications at up to 99% accuracy. The model can adapt to different scenarios, removing ...

GT Medical Technologies, a company focused on improving the lives of patients with brain tumors, today announced the interim results from its ROADS clinical trial (Randomized Controlled Trial of ...

Researchers from Trinity College, St Patrick’s Mental Health Services, Queen’s University Belfast, Ireland, investigate use ...

Nyra Medical, a leading innovator in structural heart therapies, announced today the initiation of its first-in-human ...